All three proteins might modulate CVD risk by being involved in insulin resistance, and higher levels of FABP-4 and leptin have been associated with cardiac pathophysiology and poorer cardiovascular outcome [61, 70, 71]. The gene discussed is FABP4; the disease is Insulin resistance.